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BACKGROUND: Multiple nationwide outcome registries are utilized for quality bench-
marking between institutions and individual surgeons.
OBJECTIVE: To evaluate whether nationwide quality of care programs in the United
Kingdom and United States can measure differences in neurosurgical quality.
METHODS:Thisprospectiveobservational study comprised418 consecutive adult patients
undergoing elective craniotomy at Helsinki University Hospital between December 7, 2011
and December 31, 2012.We recorded outcome event rates and categorized them according
to British Neurosurgical National Audit Programme (NNAP), American National Surgical
Quality Improvement Program (NSQIP), and American National Neurosurgery Quality and
Outcomes Database (N2QOD) to assess the applicability of these programs for quality
benchmarking and estimated sample sizes required for reliable quality comparisons.
RESULTS: The rate of in-hospital major andminor morbidity was 18.7% and 38.0%, respec-
tively, and 30-d mortality rate was 2.4%. The NSQIP criteria identified 96.2% of major
but only 38.4% of minor complications. N2QOD performed better, but almost one-fourth
(23.2%) of all patients with adverse outcomes, mostly minor, went unnoticed. For NNAP,
a sample size of over 4200 patients per surgeon is required to detect a 50.0% increase
in mortality rates between surgeons. The sample size required for reliable comparisons
between the rates of complications exceeds 600 patients per center per year.
CONCLUSION: The implemented benchmarking programs in the United Kingdom and
United States fail to identify a considerable number of complications in a high-volume
center. Health care policy makers should be cautious as outcome comparisons between
most centers and individual surgeons are questionable if based on the programs.
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P atient safety measures together with trans-parent outcome reporting have recentlybecome a major focus of interest in
medicine. Particularly among surgical commu-
nities, such interest is understandable, as up
ABBREVIATIONS: ACS, American College of
Surgeons; AMI, acute myocardial infarction; DVT,
deep venous thromboembolism; NNAP, Neurosur-
gical National Audit Programme; NSQIP, National
Surgical Quality Improvement Program; N2QOD,
National Neurosurgery Quality and Outcomes
Database; OR, operating room; PE, pulmonary
embolism; PROMs, patient-reported outcome
measures; RR, relative risk; UTI, urinary tract
infection
to 50% of hospital errors can be traced back
to operating theaters, and more than a half of
the errors may contribute to the development
of complications.1,2 The increasing interest in
conducting systematic approaches to measure
surgical outcomes has led to the situation
where a number of nationwide complication and
outcome registries have been implemented, and
these registries are exploited to compare patient
safety and quality of care figures between institu-
tions, and even between surgeons.
In neurosurgery, the Society of British Neuro-
logical Surgeons launched in April 2014 the
Neurosurgical National Audit Programme
(NNAP), which has been mandated to publish
nationwide and transparent (open-access)
30-d (from the date of admission) mortality
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rates stratified by neurosurgeons and surgical units. The
nationally validated but voluntary quality improvement project
in the United States, the American College of Surgeons (ACS)
National Surgical Quality Improvement Program (NSQIP), was
introduced in 1999. By joining the program, hospitals can volun-
tarily report surgical results (outcome within 30 postoperative
days) on an open-access website. The NSQIP is a popular
source of big data for exploring national trends and outcomes in
neurosurgery,3-7 including cranial neurosurgery.8-16 The NSQIP
data have been criticized for systemic inaccuracies and lack
of validity in neurosurgery outcomes research, however.17 The
American Association of Neurological Surgeons has launched a
Cerebrovascular Module of the National Neurosurgery Quality
and Outcomes Database (N2QOD) in December 2014. The
database serves as a national but voluntary registry, and its primary
goal is to prospectively assess and report quality of neurosur-
gical care,18 with emphasis on clinically meaningful data for
neurosurgeons.19 Generally, developing reliable quality registers
is welcome: patient satisfaction, a poor proxy for quality of care
and postoperative morbidity,20 has emerged as a popular metric
for quality of care in a variety of uses ranging from hospital
reimbursement in the United States21 to public internet-based
comparisons between treatment centers in Australia.22
We aimed to evaluate how accurately the used outcome
variables in these quality programs reflect complication rates after
elective cranial neurosurgery in a high-volume academic center,
and whether the programs serve their purpose in quality of care
comparisons in major surgery.
METHODS
Ethics Statement
The Ethics Committee of the Hospital District of Helsinki
and Uusimaa reviewed and approved this study (DNRO
127/13/03/02/2011). We followed the principles of the World Medical
Association’s Declaration of Helsinki 2013 revision. All subjects gave a
written informed consent before data collection.
Study Area
In Finland, all intracranial neurosurgical operations are performed in
one of the five public university hospitals, of which Helsinki University
Hospital is the largest with a catchment area of nearly 2 million people.
Helsinki University Hospital is a large hospital organization with 21
hospitals, over 22 000 employees and over 100 000 annual surgical proce-
dures. The total population in Finland at the end of 2012 was 5 426 674
people.
Patient Cohort and Data Collection
The patient cohort, data collection methods, and enrollment protocol
have been described in detail previously.20,23,24 In brief, a consec-
utive series of 418 adult (≥18 yr) patients, who underwent elective
craniotomies between December 7, 2011 and December 31, 2012
in the Department of Neurosurgery, (http://www.hus.fi/en/medical-
care/medical-services/Neurosurgery) of Helsinki University Hospital
(http://www.hus.fi/en) , were enrolled at the time of the first craniotomy.
Prospective data collection persisted until death or for 30 d, whichever
came first. We conducted a structured follow-up telephone interview at
30 d to evaluate postoperative outcome and functional status. The study
had no impact on the standard in-hospital treatment and care.
Recorded Outcomes
Outcome measures included in-hospital mortality, 30-d mortality,
and in-hospital morbidity as defined previously. 20,24 In this study,
major morbidity included 30-d postoperative mortality, deep venous
thromboembolism (DVT), pulmonary embolism (PE), acute myocardial
infarction (AMI), pneumonia, sepsis, a new or worsened hemiparesis
or radiological stroke (transient or permanent), and unplanned recran-
iotomies or endovascular interventions. Minor postoperative morbidities
included new or worsened facial nerve palsy, meningitis/wound
infection, minor infections such as urinary tract infection (UTI), visual
impairment (also subjective), dysphasia/dysarthria, dysphagia, andminor
cranial reoperations in the operating room (OR). Overall morbidity
comprised both major and minor morbidity.
OutcomeMeasures in Nationwide Big Data Registries
The sole outcome measure reported in the British NNAP is 30-d
(from the date of surgery) mortality (Table 1). The NSQIP program
in the United States collects data on 136 variables, of which at
least 20 are suitable as 30-d outcome measures in cranial neuro-
surgery (Table 1). These variables are surgical site infection (super-
ficial, deep, and organ), wound disruption, pneumonia, unplanned
reintubation, PE, ventilator >48 h, progressive renal insufficiency, acute
renal failure, UTI, peripheral nerve injury, stroke/cerebrovascular attack
with neurological deficit, coma >24 h, cardiac arrest requiring CPR,
myocardial infarction, graft/prosthesis/flap failure, bleeding transfusions,
DVT/thrombophlebitis, sepsis, septic shock, and return to operation
room (OR; Table 1). Both the NNAP and the NSQIP are adminis-
trative registries. The cerebrovascular module of the N2QOD has been
introduced by the American Association of Neurological Surgeons, and
includes 19 outcome variables in total (Table 1). Of these, 10 variables
are recorded before hospital discharge (neurological events, respiratory
events, cardiac events, renal events, hepatic dysfunction during the hospi-
talization, infectious disease events, hypercoagulation events, metabolic
events, other events, and unplanned return toOR during hospitalization)
and 5 post discharge up to 30 postoperative days (readmission to hospital
within 30 d of surgery, return to OR within 30 d of surgery, patient died
within 30 d of surgery). Additionally, modified Rankin Scale and global
health scale are recorded both at 6-mo and at 12-mo follow-up (optional).
The N2QOD is a clinically oriented registry.
Statistical Methods
We described the rates of individual complications and composite
outcomemeasures (major andminor morbidity) as well as 30-dmortality
in our prospective cohort. To estimate sample sizes needed to reliably
compare two proportions (complication rates) we used a 2-sample, 2-
sided equality test based on the following hypotheses:
H0 : pA − pB = 0,H1 : pA − pB = 0
Where pA is the proportion in group A and pB in group B.We assumed
equal sample sizes:
κ = ηA
ηB
= 1
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TABLE 1. Outcome Events in National Quality Registers and 1-yr Prospective Cohort. An “I” Indicates the Outcome Event is Included in Each
Individual Register. Outcome Events MarkedWith an “X”are not Included in the Register
Prospective NSQIP N2QOD NNAP
SSI I I Infectious disease event X
Sepsis I I Infections disease event X
Septic shock I Infections disease event X
Urinary tract infection I I Infections disease event X
Pneumoniaa I I Infections disease event X
Unplanned reintubation X I Respiratory event X
Ventilator> 48 h X I Respiratory event X
Progressive renal insufficiency X I Renal event X
Acute renal failure X I Renal event X
Cardiac arrest requiring CPR I I Cardiac event X
Myocardial infarction I Cardiac event X
Pulmonary embolism I I Hypercoagulation event X
DVT/thrombophlebitis I I Hypercoagulation event X
Stroke/CVA with neurological deficit I I Neurological event X
Facial nerve palsy/peripheral nerve injury I I Neurological event X
Dysphasia/dysarthria I X Neurological event X
Dysphagia I X Neurological event X
Visual impairment I X X X
Return to OR during hospitalization I I I X
Return to OR within 30 d I I I X
Wound disruption X I X X
Coma> 24 h X I X X
Bleeding requiring transfusions X I X X
graft/prosthesis/flap failure X I X X
Metabolic events X X I X
Other events X X I X
Hepatic dysfunction during hospitalization X X I X
Re-admit to hospital within 30 d X X I X
Silent stroke I X X X
In-hospital mortality I X X X
30-d mortality I I I I
Abbreviations: CPR, cardiopulmonary resuscitation; CVA, cerebrovascular attack; DVT, deep venous thromboembolism; NNAP, National Neurosurgery Audit Programme; N2QOD,
National Neurosurgery Quality and Outcomes Database; NSQIP, National Surgical Quality Improvement Program; OR, operating room; SSI, surgical site infection.
aAlso included in respiratory events.
We then used the following formulas to calculate sample sizes:
ηA = ηB,
ηA =
{
z1−α/2 ×
√
p× q ×
(
1 + 1
k
)
+ z1−β ×
√
pA × qA +
(
pB × qB
k
)}2
/2
qA = 1 − pA
qB = 1 − pB
p = pA + kpB
1 + K
q = 1 − p
where zα/2 is the critical value of the normal distribution at α/2 and zβ
is the critical value of the normal distribution at β. Additionally, we
estimated sample sizes for a relative risk (RR) of 2 with a 2-sided test
suitable for unmatched case/control studies using the same hypotheses
and assumptions as described above. The previously presented formula
with the following assumptions served for the calculations:
pB = pA × RR/ (1 + pA × (RR − 1))
RESULTS
Patient Characteristics and Surgeries
The patient characteristics of the 418 study patients are
presented in Table 2. The age of the 418 patients varied between
18 and 87 yr, and more than half (62%) were women. The age
was ≤40 yr in 14% of the patients, and ≥70 yr in 16%. Only
13 (3%) patients were 80 yr old or older. Vascular lesions, benign
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TABLE 2. Basic Demographic and Surgery-Related Factors for 418
Consecutive Elective Craniotomy Patients Categorized by the Type
of the Lesion
Variables Patients n= 418
Age (years)
Mean (range) 56.4 (18-87)
Median 58.0
Sex n (%)
Female 260 (62.2)
Male 158 (37.8)
In-hospital mortality n (%) 4 (1.0%)
30-d mortality n (%) 10 (2.4%)
tumors, and malignant tumors accounted for more than 90% of
surgeries.
Outcome Events in Prospective Cohort
The in-hospital and 30-d mortality rates were low (Table 2).
Almost one-half (46.4%) of the patients had at least one recorded
major or minor complication. The rates of overall, major, and
minor morbidity are presented in Table 3. The detailed numbers
of individual postoperative major and minor complications in
different indication groups are summarized in Table 4. The
percentage of patients with overall, major, and minor morbidity
in the prospective cohort identified by the reporting criteria of
NNAP, NSQIP, and N2QOD are depicted in Figure. All but one
of the 10 patients who died within 30 postoperative days had at
least one recorded complication. The most frequent complica-
tions reported among the deceased patients were pneumonia (3
patients), hemiparesis or a radiological stroke (3 patients), and
AMI (2 patients).
Outcome Events According to NNAP
The only outcome event reported in the NNAP is 30-d
mortality. Presuming the recorded 30-d mortality rate of 2.4%
in our prospective cohort, detecting a statistically significant
(α = 0.05, power 0.9) 50% increase in 30-d mortality between
two surgeons would require a sample size of 4245 patients per
surgeon or per center. Thus, assuming statistical significance is
defined as P ≤ .05, the mortality difference of 10 vs 15 patients
could be explained by chance variation if sample size is less than
4245 in a nontime-dependent analysis.
Outcome Events According to NSQIP
The NSQIP criteria identified 96.2% of major morbidity
but only 38.4% of minor morbidity in our prospective cohort
(Figure). All patients with new or worsened hemiparesis, the most
common individual major morbidity (9.8%) in our cohort, were
identified according to NSQIP criteria.
Using the NSQIP program, detecting a statistically significant
difference (α = 0.05, power 0.9) between one treatment center
with a hemiparesis rate of 5% and another of 10% would require
a sample size of 582 patients from each center or each surgeon
(Table 5). If estimating differences between other individual
major complications, which were more infrequent, even larger
sample sizes are necessary (Table 5). If using a composite outcome
measure (for example, the rate of major complications in our
cohort was 18.7%) instead of single NSQIP criteria, detecting a
statistically significant (α = 0.05, power 0.9) difference between
two centers with major complication rates of 10% and 20%
would require a sample size of 266 patients from each center.
Outcome Events According to N2QOD
Altogether, 149 (76.8%) patients with major or minor compli-
cations in our cohort were identifiable by N2QOD criteria.
Separate analyses for individual complications are not feasible
as N2QOD uses composite outcome events. The N2QOD
composite events identified 96.2% ofmajormorbidity and 70.4%
of minor morbidity reported in our prospective cohort (Figure).
According toN2QODcriteria, the overall morbidity rate in our
cohort was only 35.6%; almost a fourth (23.2%) of all patients
with complications (35.6% vs 46.4%) went unnoticed. To detect
a statistically significant (α = 0.05, power 0.9) difference between
two centers with complication rates of 36% and 46%, the
TABLE 3. Summary of the Frequency of Major Morbidity, Minor Morbidity, and Overall Morbidity in Patients Categorized by Indication for
Craniotomy and ageDichotomized at≥ 64 yr. BothOutcomes Comprise PatientsWith 1 orMultiple Complications. In Case BothMajor andMinor
ComplicationsWere Identified, the Individual is Included in Each Category
Patients Major morbidity Minor morbidity Overall morbidity
patients (%) patients (%) patients (%)
All (n= 418) 78 (18.7) 159 (38.0) 194 (46.4)
Age≥ 64 (n= 138) 38 (27.5) 53 (38.4) 73 (52.9)
Vascular (n = 138) 15 (10.9) 56 (40.6) 62 (44.9)
Age≥ 64 (n= 33) 7 (21.2) 20 (60.6) 22 (66.7)
Benign (n= 135) 29 (21.5) 58 (43.0) 69 (51.1)
Age≥ 64 (n= 49) 15 (30.6) 17 (34.7) 25 (51.0)
Malignant (n = 121) 31 (25.6) 38 (31.4) 55 (45.5)
Age≥ 64 (n= 49) 16 (32.7) 14 (28.6) 24 (49.0)
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TABLE 4. Rates of Recorded Postoperative Complications by Indication
Complication All Vascular lesion Benign tumor Malignant tumor Other
(n= 418) n (%) (n= 138) n (%) (n= 135) n (%) (n= 121) n (%) (n= 24) n (%)
New or worsened hemiparesis 41 (9.8) 10 (7.2) 14 (10.4) 17 (14.0) 0 (0.0)
Silent stroke 6 (1.4) 1 (0.7) 3 (2.2) 2 (1.7) 0 (0.0)
Deep venous thromboembolism 2 (0.5) 0 (0.0) 0 (0.0) 2 (1.7) 0 (0.0)
Pulmonary embolism 3 (0.7) 0 (0.0) 1 (0,7) 2 (1.7) 0 (0.0)
Acute myocardial infarction 4 (1.0) 0 (0.0) 3 (2.2) 1 (0.8) 0 (0.0)
Pneumonia 14 (3.3) 6 (4.3) 4 (3.0) 4 (3.3) 0 (0.0)
Unplanned re-craniotomy or endovascular interventiona 17 (4.1) 1 (0.7) 8 (5.9) 7 (5.8) 1 (4.2)
Wound infection, meningitis 9 (2.2) 4 (2.9) 3 (2.2) 2 (1.7) 0 (0.0)
Minor infections (for example urinary tract infection) 39 (9.3) 17 (12.3) 9 (6.7) 8 (6.6) 5 (20.8)
Postoperative visual impairment 76 (18.2) 33 (23.9) 24 (17.8) 16 (13.2) 3 (12.5)
New or worsened facial nerve Palsy 14 (3.3) 0 (0.0) 8 (5.9) 6 (5.0) 0 (0.0)
Dysphasia, dysarthria 49 (11.7) 12 (8.7) 19 (14.1) 18 (14.9) 0 (0.0)
Dysphagia 26 (6.2) 10 (7.2) 12 (8.9) 4 (3.3) 0 (0.0)
Unplanned minor cranial reoperationsin the operating rooma 3 (0.7) 0 (0.0) 3 (2.2) 0 (0.0) 0 (0.0)
aOverall, 19 (4.5%) patients had an unplanned reoperation involving the head during the 30-d follow-up, 12 (2.9%) patients before discharge and an additional 7 (2.2%) patients
during days 7 to 30 after the first surgery. Of all reoperated patients, 16 underwent a recraniotomy, 1 patient twice. Of the 2 patients who had a ventriculostomy, one underwent
a subsequent recraniotomy. Two patients had a cerebrospinal fluid fistula repaired, 1 patient coiling of an intracranial aneurysm, and 1 patient had surgical wound revision. The
reoperations resulted in further complications in 5 patients (26.3% of the reoperations).
FIGURE. The accuracy (%) of nationwide neurosurgical quality programs
in detecting postoperative overall, major and minor morbidity compared to
prospective complications data in elective cranial neurosurgery in Helsinki
University Hospital. Abbreviations: NNAP, Neurosurgical National Audit
Programme; N2QOD, National Neurosurgery Quality and Outcomes
Database; NSQIP, American College of Surgeons National Surgical Quality
Improvement Program.
required sample size would be 416 patients from each center, a
number only feasible in the largest neurosurgical centers.
DISCUSSION
The annual number of elective craniotomies in a majority of
neurosurgical units rarely exceeds 600, a number required to
statistically detect a significant difference in the incidence of the
most common complication—new or worsened hemiparesis—
between two centers. Composite outcomemeasures may serve the
purpose to satisfy the power requirement for detecting significant
differences between centers surveyed in large national registries.
Despite being important pioneers in patient safety and quality
of care improvement, however, results from these registers should
be interpreted with caution, especially since contributing data is
voluntary and systemic data inaccuracies have been observed.17
By 2017, it is estimated that about 9% of Medicare payments to
hospitals will be based on reporting and performance of quality
metrics,25 implicating a strong financial incentive behind partici-
pating in these programs. Particularly surgeon-specific outcome
reporting of rare complications such as mortality from the
registries seems inadequate in major surgery, such as neuro-
surgery.
The strengths of our study include the prospective study
design, consecutive and unselected cohort of patients, high-
volume academic center (minimal selection bias), and multiple
surgeons (increased external validity). Cumulative sums of
individual complications can only be reported from prospective
cohorts. The study also has weaknesses. First, the cohort size
of 418 patients is relatively small, despite the fact that the
study was conducted in a high-volume neurosurgical unit. It
should be noted, however, that in large register-based studies,
the caseloads of individual participating hospitals are often much
lower. Furthermore, the studied outcome programs are meant
for a clinical use in neurosurgical units, most of which have
smaller caseloads than the study hospital. Large-scale multicenter
or even multinational studies are needed to confirm our findings
and their generalizability. Despite rigorous efforts to record all
postoperative complications reported both by physicians and by
patients themselves, it is possible that some complications went
unidentified. To improve the data collection, neurosurgical units
should routinely record patient-reported complications data and
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TABLE 5. Sample SizeCalculations forDetecting aStatistically SignificantDifference in theHypotheticallyDoubledComplicationRatesBetween
2 Surgeons
Complication rates
Surgeon A 0.5% 1.0% 2.0% 5.0% 10.0% 20.0% 30.0%
Surgeon B 1.0% 2.0% 4.0% 10.0% 20.0% 40.0% 60.0%
2-sample, 2-sided equality
N per surgeon
power (1-β)= 0.8, α = 0.05 4673 2319 1141 435 199 82 42
power (1-β)= 0.9, α = 0.05 6256 3103 1527 582 266 109 56
N total
power (1-β)= 0.8, α = 0.05 9346 4638 2282 870 398 164 84
power (1-β)= 0.9, α = 0.05 12 512 6206 3054 1164 532 218 112
Risk ratio= 2
N per surgeon
power (1-β)= 0.8, α = 0.05 4752 2398 1221 516 283 172 141
power (1-β)= 0.9, α = 0.05 6361 3209 1634 690 378 230 188
N total
power (1-β)= 0.8, α = 0.05 9504 4796 2442 1032 566 344 282
power (1-β)= 0.9, α = 0.05 12 722 6418 3268 1380 756 460 376
Abbreviations: α, type I error; β , type II error; N, Number of patients.
strive for the efficient utilization of structured data available in
electronic patient records.
According to our results, in-hospital and 30-d mortality rates
in modern neurosurgery are so low, that mortality is inadequate
as a sole measure in outcome comparisons. In our hospital, a
30-d mortality rate per neurosurgeon is one event every second
year on average. The required sample size for detecting true
differences between two surgeons is considerably larger than
the lifetime caseload of an individual neurosurgeon even in the
largest neurosurgical centers. The Society of British Neurosur-
geons, however, “recognizes the national clinical audit as a key
approach to improving patient care, outcomes, safety and sees the
NNAP as a key driver of this process”.26 The public reporting of
surgeon-specific mortality rates has already lead to a reluctance
among surgeons to accept difficult surgical cases in an effort to
avoid higher-than-expected mortality statistics.27,28 Our results
question the use of mortality, even if risk-adjusted, as a sole
measure of quality of care in cranial neurosurgery.
Regardless of its popularity as a data source for neurosur-
gical outcome research, the NSQIP database has received no
external validation for accuracy and the results of Rolston and
coworkers indicate evidence of Current Procedural Terminology
code and postoperative diagnosis mismatch in 0.4% to 100.0%
of cases.17 Furthermore, the NSQIP has served for developing a
novel preoperative frailty score for predicting 30-d morbidity and
mortality after cranial neurosurgery,29 however, the ACS universal
risk calculator based on the same data source is discriminative
only for 30-d mortality but not other adverse events in neurosur-
gical patients.30 Even though the NSQIP criteria detected a high
percentage of patients with major complications in our cohort,
limited caseloads in individual hospitals along with the rarity
of outcome events hinders the sensible use of such registries.31
Furthermore, registries that rely on administrative data with
little disease-specificity lack the level of clinical detail required
for true quality improvement.32 Despite the wide contribution
and claimed benefits, recent alarming reports have shown no
association between participating in NSQIP and improvement in
patient outcomes.33,34
As the first national prospective registry focusing on outcome
and quality of care in neurosurgery, the N2QOD holds great
expectations for benchmarking and true comparisons between
treatment centers. Such prospective multicenter data may be
considered more reliable, specialty-specific and clinically relevant
than previous retrospective analyses of administrative data.35
The N2QOD employs composite outcome events instead
of individual complications, which reduces the sample size
requirement for reliable comparisons between treatment centers.
The N2QOD criteria, however, failed to identify almost a fourth
of all patients with postoperative complications reported in
our prospective cohort, indicating that the criteria may not be
sensitive for minor complications that may still have a great
impact on the recovery and postoperative quality of life after
major surgery.
Our results highlight that the medical community, policy-
makers, and other stakeholders need to be very careful not to
assess and quantify the quality of care—a principal measuring tool
not only for patient safety but also for financial reimbursement
in health care—with unreliable or inadequate instruments.
Measuring the quality of care should be based on strong
scientific evidence, just like the clinical care we deliver to our
patients. To meet the requirements of heavy-handed government
regulation and to avoid financial penalties, health care
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facilities including neurosurgical centers are forced to partic-
ipate in multiple overlapping quality programs.35 The programs
fail to adjust for case-specific circumstances, and as a result high-
risk patients struggle to find physicians willing to operate due to
a punitive component associated with the quality databases.35,36
Even though complete transparency in outcomes reporting is
imperative, it is crucial that public outcomes reporting such as
the NNAP surgeon-specific mortality rates or the Centers for
Medicare and Medicaid Services Physician Compare website
reflect the level of patient health literacy. Furthermore, intercul-
tural differences in healthcare and funding systems hinder the
worldwide applicability of quality registers without a careful and
thorough validation process.
In the future, instead of institutional or doctor-dependent
definitions and reporting of adverse outcome events,
patient-centered reporting approaches, such as patient-
reported outcomes24 and patient-reported outcome measures
(PROMs),37,38 are promising options for monitoring quality
of care in neurosurgery. To promote patient safety and patient
centeredness, the neurosurgical community should strive for a
prompt consensus on outcome events and outcomes reporting,
including validating neurosurgery-specific PROMs. This would
also be a crucial step towards developing a neurosurgery-specific
risk-assessment method, which would facilitate benchmarking
by enabling corrections for differences in the case-mix between
treatment centers.
CONCLUSION
In order to improve the quality of care and patient safety
in major surgeries, such as neurosurgery, mortality, and admin-
istrative data have limited value in providing reliable tools for
quality of care comparisons and patient safety initiatives. In
neurosurgery, despite being driven undoubtedly by the best of
intentions, the current quality registers may backfire on the
neurosurgical community and on a larger scale the whole medical
profession. The physicians need to take the lead in designing
reliable and accurate quality measures, interpreting the results and
utilizing them to power intelligent changes in health care to truly
improve the quality of care.
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COMMENT
T he authors performed a prospective evaluation of 418 adult patientsoperated in a neurosurgical center. They compared 3 different neuro-
surgical quality registries of the US andUK based on the outcome of their
patient collective. The failure of all programs to recognize major postop-
erative complications is an important conclusion of this study, especially
since funding is and will be attached to these registries. It is of utmost
importance for neurosurgical centers to analyze quality data bases in
order to discover limitations and enable improvement. This study could
not be timelier, since the implementation of value-based healthcare is a
present, ongoing discussion. The definition and expectations of quality
as an outcome factor has been thoroughly discussed, how to measure it
however, is the biggest challenge.
Eric Suero Molina
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